Tara Sander Lee, Ph.D.Vice President and Director of Life Sciences
Tara Sander Lee, Ph.D., is Vice President and Director of Life Sciences at the Charlotte Lozier Institute, a research organization focused on science and statistics for life.
A scientist with over 20 years’ experience in academic and clinical medicine with an emphasis on the cause of pediatric disease, Dr. Sander Lee earned a Ph.D. in Biochemistry from the Medical College of Wisconsin followed by postdoctoral training at Harvard Medical School and Boston Children’s Hospital in molecular and cell biology. Dr. Sander Lee was an appointed faculty member at the Medical College of Wisconsin, where she directed a research laboratory investigating congenital heart disease in children and served as Scientific Director of Molecular Diagnostics at Children’s Hospital of Wisconsin. She has also served as a scientific consultant and is currently a member of the U.S. Secretary of Health and Human Services Advisory Committee on Infant and Maternal Mortality.
Dr. Sander Lee is dedicated to promoting ethical advancements in healthcare that protect the sanctity of every human life. She has been invited to give expert legislative testimony, given numerous national media interviews, and provided scientific advice for legislators, policymakers, and organizations. Dr. Sander Lee is published in various medical journals and textbooks, including her most recent contribution to the book, Choose Life: Answering Key Claims of Abortion Defenders with Compassion. She is also lead editor of VoyageOfLife.com, a website that reveals the remarkable journey of every human being in the womb from conception to birth, and how we are each “fearfully and wonderfully” made.
To learn more about Dr. Sander Lee’s journey as a pro-life scientist, please see this video:
Dr. Tara Sander Lee, Ph.D., and Dr. Ingrid Skop, M.D., join Nebraska's Spirit Catholic Radio to discuss what science says about the proposed Nebraska Heartbeat Act.
What does it say about America if our leading cultural institutions, such as a major political party and their legions of allies in the media, do the abortion industry’s dirty work by ignoring or suppressing the science? What does it say about us if we let them?
A Handbook of Bioethical Considerations Regarding Nascent Human Beings and Their Cells (Handbook II)
The purpose of this handbook is to provide a useful reference guide to understanding ethical and moral implications for scientific experimentation involving nascent human beings and cells derived from nascent human beings. In particular, the attributes of nascent human beings and cells derived from them are presented in the context of their moral significance and bioethics considerations regarding the permissibility of their use in biomedical research.
Advancements in science and medicine over the past 50 years have paved the way for the “Perinatal Revolution”—recognizing the unborn child as a separate patient and offering life-saving care before birth.
The purpose of this handbook is to provide a useful reference guide to understanding the biological nature and properties of nascent human beings and cells derived from nascent human beings.
“We need to consider these young individuals as equally valued human lives. Eliminating young lives is not the answer to eliminating disease and disability once a risk of the disorder is identified. Destroying the patient is not curative medicine. Such acts become a modern-day form of eugenics.”
The trafficking of aborted baby body parts for research is barbaric. The Trump administration was dedicated to ending this practice and protecting the sanctity of human life. Grave injustices were exposed that exploited unborn children for experimentation, but were not fully remedied.
Written Testimony of Dr. Tara Sander Lee on South Dakota’s HB 1110 to Prohibit Abortions due to Down Syndrome
Dr. Tara Sander Lee testified on HB 1110, noting her scientific and clinical experience spanning 20 years, which includes expertise in molecular genetics and diagnostic testing. Dr. Sander Lee provided information on: the incidence of Down syndrome in the United States, methods of prenatal screening and testing, the high false-positive rate of incorrect reporting in standard screening tests, limitations with newer methods of non-invasive prenatal screening (NIPS or NIPT), and the “perinatal revolution”
“Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells. CLI has reviewed the published information and our conclusion is straightforward: The president was not given any medicines to treat COVID-19 that involved the destruction of human life. No human embryonic stem cells or human fetal tissue were used to produce the treatments President Trump received--period.
Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research. First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.